These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 8329003

  • 1. Cardiovascular properties of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N- methylbenzamide.
    Hirohashi M, Takasuna K, Asano M, Ryokawa Y, Tamura K.
    Arzneimittelforschung; 1993 May; 43(5):578-83. PubMed ID: 8329003
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M, Takasuna K, Yamashita N, Tamura K.
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [Abstract] [Full Text] [Related]

  • 3. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M, Takasuna K, Kasai Y, Usui C, Tamura K, Kojima H.
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [Abstract] [Full Text] [Related]

  • 4. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
    Asano M, Kurebayashi Y, Ryokawa Y, Hashizume T, Akashi A.
    Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
    [Abstract] [Full Text] [Related]

  • 5. Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats.
    Sharma AC, Gulati A.
    J Lab Clin Med; 1994 Feb; 123(2):299-308. PubMed ID: 8301207
    [Abstract] [Full Text] [Related]

  • 6. [Effects of the anti-ulcer drug SU-88 on the gastric blood flow and the cardiovascular system (author's transl)].
    Saziki R, Arai I, Isobe Y, Aihara H.
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):193-202. PubMed ID: 7084818
    [Abstract] [Full Text] [Related]

  • 7. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M, Yajima M, Nishimura T, Ikeda H, Nishimori T.
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [Abstract] [Full Text] [Related]

  • 8. Generalized cardiovascular and regional hemodynamic effects of meperidine in conscious dogs.
    Priano LL, Vatner SF.
    Anesth Analg; 1981 Sep; 60(9):649-54. PubMed ID: 7196709
    [Abstract] [Full Text] [Related]

  • 9. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
    Merlo L, Ghirardi P, Brusoni B, Mussini E, Marchetti G.
    Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
    [Abstract] [Full Text] [Related]

  • 10. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
    Kushiku K, Morishita H, Furukawa T, Kitagawa H, Ueno K, Kitagawa H, Kohei H.
    Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
    [Abstract] [Full Text] [Related]

  • 11. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K.
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [Abstract] [Full Text] [Related]

  • 12. Regional effects of dobutamine in endotoxic shock.
    De Backer D, Zhang H, Manikis P, Vincent JL.
    J Surg Res; 1996 Oct; 65(2):93-100. PubMed ID: 8903453
    [Abstract] [Full Text] [Related]

  • 13. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl] propionic acid hydrochloride on gastric mucosal blood flow.
    Hoshina K, Okada N, Inoue K, Yamamoto M, Saito N, Takeshita T, Naruchi T.
    Arzneimittelforschung; 1987 Nov; 37(11):1284-9. PubMed ID: 3440037
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular effects of 1-(3,4-dimethoxyphenyl)-2-(4-diphenylmethylpiperazinyl) ethanol and possible mechanisms involved.
    Kushiku K, Ohba M, Araki T, Mikagi T, Katsuragi T, Furukawa T.
    Arzneimittelforschung; 1989 Apr; 39(4):458-63. PubMed ID: 2751731
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
    Ikeo T, Nagao T, Murata S, Yabana H, Sato M, Nakajima H.
    Arzneimittelforschung; 1986 Jul; 36(7):1063-8. PubMed ID: 3768073
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs.
    Higashio T, Tsuji Y, Nakao K, Sakaguchi S, Tanaka M.
    Arzneimittelforschung; 1988 Mar; 38(3):350-8. PubMed ID: 3382459
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the cardiovascular, renal, and coronary effects of dopamine and monensin in endotoxic shock.
    Somani P, Saini RK.
    Circ Shock; 1981 Mar; 8(4):451-64. PubMed ID: 7023738
    [Abstract] [Full Text] [Related]

  • 18. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
    Imamoto T, Tanabe M, Shimamoto N, Kawazoe K, Hirata M.
    Arzneimittelforschung; 1984 Mar; 34(2):161-9. PubMed ID: 6539108
    [Abstract] [Full Text] [Related]

  • 19. Functional role of alpha-calcitonin gene-related peptide in the regulation of the cardiovascular system.
    Shen YT, Pittman TJ, Buie PS, Bolduc DL, Kane SA, Koblan KS, Gould RJ, Lynch JJ.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):551-8. PubMed ID: 11454916
    [Abstract] [Full Text] [Related]

  • 20. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T, Ukai K, Masuda T, Nakagawa T, Kimura K, Fujii M, Wakatsuki K, Saeki M, Kasai H.
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.